Key result
Magnetic resonance imaging accurately assessed the degree and distribution of apical hypertrophy in all 10 HCM patients, including 4 patients where two-dimensional echocardiography was inadequate.
Why the study?
Does magnetic resonance imaging improve the assessment of apical hypertrophy in patients with hypertrophic cardiomyopathy compared to two-dimensional echocardiography?
Observational (n=10)
Does magnetic resonance imaging improve the assessment of apical hypertrophy in patients with hypertrophic cardiomyopathy compared to two-dimensional echocardiography?
Magnetic resonance imaging provides an accurate assessment of myocardial hypertrophy in HCM patients, particularly when wall thickening is localized to the apical portion and echocardiography is inadequate.
No takes yet. Share an insight, caveat, or question.
MRI may aid apical HCM assessment when echocardiography is limited; leaves open larger prospective validation before practice change.
Gaudio et al. (1992) conducted an observational in Hypertrophic cardiomyopathy (HCM) (n=10). Magnetic resonance imaging vs. Two-dimensional echocardiography was evaluated on Assessment of the degree and distribution of apical hypertrophy. Magnetic resonance imaging accurately assessed the degree and distribution of apical hypertrophy in all 10 HCM patients, including 4 patients where two-dimensional echocardiography was inadequate.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: